Patient Guide: Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 28 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07407465
Status: 🟢 Enrolling Now
Condition: Colorectal Cancer, Colorectal Adenocarcinoma, Rectal Adenocarcinoma, Rectal Cancer, Adenocarcinoma, Rectal Cancer, Metastatic, Colon Cancer Metastatic, Colon Cancer Adenocarcinoma
Phase: PHASE2

Find a Study Location Near You

This study is available at 28 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Lyon,
  • Marseille,
  • Paris,
  • • And 25 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily